Vka
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
128 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | 2 | 8 | 6 | 48 | 64 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | 4 | 1 | 12 | 17 |
| Thrombosis | D013927 | — | — | — | 3 | 4 | 1 | 7 | 15 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | 2 | 10 | 13 |
| Embolism | D004617 | — | — | — | — | 3 | 2 | 6 | 11 |
| Venous thrombosis | D020246 | HP_0004936 | I82.40 | — | 1 | 3 | 1 | 2 | 7 |
| Pulmonary embolism | D011655 | HP_0002204 | I26 | — | — | 3 | 1 | 2 | 6 |
| Ischemic stroke | D000083242 | — | — | — | — | — | 1 | 4 | 5 |
| Syndrome | D013577 | — | — | — | 1 | — | 2 | 1 | 4 |
| Coronary artery disease | D003324 | — | I25.1 | — | — | — | 1 | 2 | 3 |
Show 9 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thromboembolism | D013923 | HP_0001907 | — | — | 1 | 3 | — | 13 | 17 |
| Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | 1 | 3 | — | 11 | 15 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 3 | — | — | 4 |
| Aortic valve stenosis | D001024 | HP_0001650 | — | — | — | 2 | — | — | 2 |
| Transcatheter aortic valve replacement | D065467 | — | — | — | — | 2 | — | — | 2 |
| Rheumatic heart disease | D012214 | EFO_1001161 | I09.9 | — | — | 2 | — | — | 2 |
| Rheumatic diseases | D012216 | — | M79.0 | — | — | 2 | — | — | 2 |
| Percutaneous coronary intervention | D062645 | — | — | — | — | 1 | — | 1 | 2 |
| Pathologic constriction | D003251 | — | — | — | — | 1 | — | — | 1 |
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | — | 1 | — | — | 1 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Antiphospholipid syndrome | D016736 | EFO_0002689 | D68.61 | — | 1 | — | — | 2 | 3 |
| Healthy volunteers/patients | — | — | — | 1 | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | — | — | 2 | 2 |
| Emergencies | D004630 | — | — | — | — | — | — | 2 | 2 |
| Neoplasms | D009369 | — | C80 | — | — | — | — | 2 | 2 |
| Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | — | — | — | — | 2 | 2 |
| Hemostatic disorders | D020141 | — | — | — | — | — | — | 2 | 2 |
| Intracranial hemorrhages | D020300 | EFO_0000551 | I62 | — | — | — | — | 2 | 2 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 2 | 2 |
| Cerebral hemorrhage | D002543 | — | — | — | — | — | — | 2 | 2 |
| Arterial occlusive diseases | D001157 | EFO_0009085 | — | — | — | — | — | 1 | 1 |
| Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Show 21 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use